| Product Name | MF | CAS | Details |
|---|
| 5,6-trans-(±)-Cloprostenol/(5E)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid | C22H29ClO6 | 72029-43-7 | Details |
| Bortezomib impurity 2/(1S,2R)-Bortezomib | C19H25BN4O4 | 1132709-16-0 | Details |
| 15S-Cloprostenol/15-epi Cloprostenol/(5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-Chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid | C22H29ClO6 | 54276-22-1 | Details |
| Calcipotriol EP Impurity F/1,3-Bis-O-(tert-butyldimethylsilyl)calcipotriene | C39H68O3Si2 | 112875-61-3 | Details |
| Bortezomib impurity 3/(1S,2S)-Bortezomib | C19H25BN4O4 | 1132709-14-8 | Details |
| Riociguat Impurity 2/1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide | C14H11FN4O | 256376-62-2 | Details |
| Rivaroxaban impurity 3/ Dechloro-Rivaroxaban/N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide | C19H19N3O5S | 1415566-28-7 | Details |
| Rivaroxaban impurity 1/(S)-N-[{3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl}methyl]acetamide | C16H19N3O5 | 1429334-00-8 | Details |
| 15-Keto Travoprost/(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoic acid 1-methylethyl ester | C26H33F3O6 | 404830-45-1 | Details |
| Dapagliflozin impurity 7/Dapagliflozin Open ring/(1S,2S,3R,4R,5R)-1-(4-chloro-3-(4-ethoxybenzyl)phenyl)hexane- 1,2,3,4,5,6-hexaol | C21H27ClO7 | 2100872-88-4 | Details |
| Riociguat Impurity 11/Ethyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate | C21H21FN8O2 | 625115-53-9 | Details |
| Dapagliflozin impurity 1/Ortho-Isomer Dapagliflozin/(2S,3R,4R,5S,6R)-2-(4-chloro-3-(2-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | C21H25ClO6 | 2040305-05-1 | Details |
| Doxercalciferol impurity 1/trans-Doxercalciferol | C28H44O2 | 74007-20-8 | Details |
| Atorvastatin impurity 34/(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate | C14H27NO4 | 1105067-89-7 | Details |
| 15-Keto Bimatoprost/(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E)-3-oxo-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide | C25H35NO4 | 1163135-96-3 | Details |
| Prednisolone impurity 4/Prednisolone EP Impurity F/11-epi-Prednisolone/(8S,9S,10R,11R,13S,14S,17R)-11,17-Dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl- | C21H28O5 | 600-90-8 | Details |
| Bendamustine impurity 3/Bendamustine RC B/4-(1-Methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)butanoic acid | C16H21N3O3 | 1228552-02-0 | Details |
| Dapagliflozin impurity 5/1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-Glucopyranose | C21H25ClO7 | 461432-27-9 | Details |
| 15S-(±)-Cloprostenol/(5Z)-rel-7-[(1R,2R,3R,5S)-2-[(1E,3S)-4-(3-Chlorophenoxy)-3-hydroxy-1-butenyl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid | C22H29ClO6 | 40665-93-8 | Details |
| (15R)-Bimatoprost/15-epi Bimatoprost/(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide | C25H37NO4 | 1163135-92-9 | Details |
| Bortezomib impurity 5/Bortezomib EP Impurity E | C19H24N4O3 | 289472-78-2 | Details |
| Clobetasol Propionate USP Related Compound A/(17R)-4’-Chloro-5’-ethyl-9-fluoro-11β-hydroxy-16β-methylspiro[androsta-1,4-diene-17,2’(3’H)-furan]-3,3’-dione | C25H30ClFO4 | 1486466-31-2 | Details |
| Riociguat Impurity 16/6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)-7,9-dihydro-8H-purin-8-one | C18H13FN8O | 1361569-10-9 | Details |
| Calcifediol EP Impurity C/(6E)-9,10-secocholesta- 5(10),6,8-triene-3β,25-diol | C27H44O2 | 39932-44-0 | Details |
| Latanoprost Acid/(Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid | C23H34O5 | 41639-83-2 | Details |
| Calcipotriol EP Impurity A/(1α,3β,5Z,7E,22E)-24-Cyclopropyl-1,3-dihydroxy-9,10-Secochola-5,7,10(19),22-tetraen-24-one | C27H38O3 | 126860-83-1 | Details |
| Rivaroxaban impurity 2/N,N'-Bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]urea | C29H32N6O9 | 1365267-35-1 | Details |
| Dexamethasone impurity 5/Dexamethasone-17-Ketone | C20H25FO3 | 2285-53-2 | Details |
| 15(S)-Latanoprost/(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester | C26H40O5 | 145773-22-4 | Details |
| 5-trans-Bimatoprost/(5E)-Bimatoprost/(5E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide | C25H37NO4 | 1163135-95-2 | Details |
| Bendamustine impurity 1/Bendamustine Impurity D/4-(6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4’,5’:5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanoic Acid | C16H20ClN3O2S | 191939-34-1 | Details |
| Dapagliflozin impurity 4/Dapagliflozin Hydroxy impurity | C21H25ClO7 | 960404-86-8 | Details |
| Dihydrocyclosporine A/6-[(2S,3R,4R)-3-Hydroxy-4-methyl-2-(methylamino)octanoic acid]cyclosporin A | C62H113N11O12 | 59865-15-5 | Details |
| Paricalcitol impurity 17/3α-Paricalcitol | C27H44O3 | 216161-87-4 | Details |
| 15-Keto Latanoprost/(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-(3-oxo-5-phenylpentyl)cyclopentyl]-5-heptenoic Acid 1-Methylethyl Ester | C26H38O5 | 135646-98-9 | Details |
| Bendamustine impurity 6/Bendamustine Related Compound F | C22H33Cl2N3O7 | 1869075-89-7 | Details |
| Edaravone impurity 5/2-(3-Methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)-2-sulfopropanoic acid | C13H14N2O6S | 1357477-99-6 | Details |
| Bendamustine impurity 7/Bendamustine Ethyl Ester/Bendamustine USP Related Compound I/Ethyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate | C18H25Cl2N3O2 | 87475-54-5 | Details |
| Dapagliflozin impurity 6/(1R)-1,4-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol | C21H25ClO6 | 1469910-83-5 | Details |
| Linezolid impurity 5/(S)-N-(3-((3-Fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)acetamide | C15H22FN3O3 | 1561176-27-9 | Details |
| Prednisolone impurity 6/Prednisolone EP Impurity J/11-Deoxy Prednisolone/17,21-Dihydroxypregna-1,4-diene-3,20-dione | C21H28O4 | 1807-14-3 | Details |
| Atorvastatin impurity 31/Atorvastatin Ethyl Ester/ethyl (3R,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate | C35H39FN2O5 | 1146977-93-6 | Details |
| Dapagliflozin impurity 3/Acetyl Dapagliflozin | C29H33ClO10 | 461432-25-7 | Details |
| Bendamustine impurity 5/Bendamustine USP Related Compound E/4-(1-Methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)butanoic Acid | C16H22ClN3O3 | 109882-27-1 | Details |
| Rivaroxaban Impurity 20/4,5-Dichloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide | C19H17Cl2N3O5S | 1770812-37-7 | Details |
| Bimatoprost Acid/(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-5-heptenoic Acid | C23H32O5 | 38344-08-0 | Details |
| Atorvastatin impurity 29/Atorvastatin Epoxydione Impurity/Atorvastatin EP Impurity D/3-(4-Fluorobenzoyl)-2-(2-methyl-1-oxopropyl)-N,3-diphenyloxiranecarboxamide | C26H22FNO4 | 148146-51-4 | Details |
| Linezolid impurity 1/Deacetyl Linezolid/(S)-5-(aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | C14H18FN3O3 | 168828-90-8 | Details |
| Montelukast impurity 10/Montelukast Ketone Impurity/1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]-1-propanone | C29H26ClNO2 | 1258428-71-5 | Details |
| Ibuprofen impurity 8/Ibuprofen EP Impurity N/(2RS)-2-(4-Ethylphenyl)propanoic acid | C11H14O2 | 3585-52-2 | Details |
| 6-alpha-Fluoro-isoflupredone | C21H26F2O5 | 806-29-1 | Details |
| Ibuprofen - In house impurity/(1-Hydroxyethyl)-4-(2-methylpropyl)benzene | C12H18O | 40150-92-3 | Details |
| Rivaroxaban impurity 4/2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione | C22H19N3O6 | 446292-08-6 | Details |
| Olanzapine impurity 4/Olanzapine Thiolactam Impurity/(1Z)-1-[4,5-Dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]-2-propanone | C17H20N4OS | 1017241-36-9 | Details |
| Calcipotriol EP Impurity C/5,6-trans-Calcipotriol/(5E)-Calcipotriene | C27H40O3 | 113082-99-8 | Details |
| Olanzapine impurity 6/2-Methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-amine | C12H11N3S | 612503-08-9 | Details |
| Ezetimibe impuriry 8/(3’S,3R,4S)-Desfluoro Ezetimibe/(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-phenylpropyl)-4-(4-hydroxyphenyl)azetidin-2-one | C24H22FNO3 | 190595-66-5 | Details |
| Rivaroxaban impurity 5/N1,N2-Bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1,2-benzenedicarboxamide | C36H36N6O10 | 1365267-36-2 | Details |
| AtorvastatinPyrrolidoneLactone | C33H33FN2O5 | 906552-19-0 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 | ||||